"Biosimilars presents a USD 240 billion global opportunity for Indian Pharmaceuticals Industry while domestic market is expected to cross USD 40 ...
Read more: Biosimilars presents USD 240 billion opportunity for Indian Pharmaceuticals Industry: Assocham ...